查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1338878

心臟標記測試市場、份額、規模、趨勢、行業分析報告：按產品類型、最終用戶、地區、細分市場、預測，2023-2032 年

Cardiac Marker Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents and Kits and Instruments); By Biomarker Type; By End-User; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球心臟標記檢測市場規模預計將達到 97.3 億美元。該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

全球急診室 (ED) 心血管疾病患者數量激增、需求不斷增長以及 POCT 等多種心臟生物標記測試的採用是推動全球市場成長的突出因素。此外，新進業者不斷進入測試市場以實現利潤最大化，而現有參與者則專注於透過投資研發活動來開發和擴大其產品組合。例如，2023年1月，Cipla宣布推出一款名為 "Cippoint" 的新測試設備，這是一款獲得CE IVD批准的床邊測試設備，可提供糖尿病、傳染病、甲狀腺功能、發炎和代謝標誌物的測試。

此外，心臟標記物的最新進展提高了特異性和可靠性，從市售儀器到心肌肌鈣蛋白和利尿鈉□等新技術，並允許在一次測定中對大量分子靶標進行多重檢測。-護理免疫測定的性能得到改善。千禧世代不健康食品消費的增加導致心絞痛患者數量增加，心臟生物標記的採用將迅速增加，以滿足該患者群體不斷增長的需求。

癌症和各種其他疾病的盛行率顯著增加，各國政府將時間和資源集中在開發醫療保健系統和取得先進的心臟標記檢測設備。例如，在美國心臟病學會進行的一項新研究中，研究人員認為ApoB 檢測可以幫助識別可能處於高心血管風險的患者，即使他們的LDL 膽固醇水平不正常。我發現了一些可能有幫助的東西。

心臟標記測試市場報告亮點

由於心臟生物標記測試的採用增加，2022 年全球市場份額將由試劑和試劑盒主導

肌鈣蛋白 I 和 T 細分市場在 2022 年佔據了重要的市場收入份額，這主要是由於對這些用於診斷急性心肌梗塞的設備的需求不斷增加。

由於主要醫療保健服務提供者的使用量不斷增加，預計在研究期間，護理點設施部分將以最高的複合年增長率增長。

由於美國和加拿大等國家在醫療保健基礎設施方面的高額支出以及先進心臟生物標記的快速採用，北美地區將在 2022 年主導全球市場。

目錄

第 1 章 簡介

第二章執行摘要

第三章研究方法論

第四章全球心臟標記檢測市場洞察

  • 心臟標記測試市場—生物標記類型概況
  • 心臟標記測試市場動態
    • 驅動因素和機遇
      • 心血管疾病發生率上升
      • 先進技術進步
    • 限制因素和挑戰
      • 樣本採集與儲存的技術問題
  • PESTEL 分析
  • 心臟標記檢測市場中生物標記類型的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第五章全球心臟標記測試市場（按產品）

  • 主要發現
  • 介紹
  • 試劑和試劑盒
  • 設備

第六章全球心臟標記檢測市場（按應用）

  • 主要發現
  • 介紹
  • 臨床檢測設施
  • 即時偵測設施
  • 學術機構

第七章全球心臟標記測試市場（按生物標記類型）

  • 主要發現
  • 介紹
  • 肌鈣蛋白 I 和 T
  • 肌酸激□-MB (CK-MB)
  • 鈉化合物
  • 肌紅蛋白
  • 高敏C反應蛋白
  • 其他心臟生物標記

第八章全球心臟標記測試市場（按地區）

  • 主要發現
  • 介紹
    • 2019-2032 年心臟標記檢測市場評估（按地區）
  • 心臟標記測試市場 - 北美
    • 北美：心臟標記測試市場（按產品），2019-2032
    • 北美：心臟標記測試市場，按生物標記類型，2019-2032
    • 北美：心臟標記測試市場，按應用分類，2019-2032
    • 心臟標記測試市場—美國
    • 心臟標記測試市場 - 加拿大
  • 心臟標記測試市場 - 歐洲
    • 歐洲：心臟標記測試市場（按產品），2019-2032
    • 歐洲：心臟標記測試市場，依生物標記類型，2019-2032
    • 歐洲：心臟標記測試市場，按應用劃分，2019-2032
    • 心臟標記測試市場—英國
    • 心臟標記測試市場—法國
    • 心臟標記測試市場 - 德國
    • 心臟標記測試市場—義大利
    • 心臟標記測試市場—西班牙
    • 心臟標記測試市場 - 荷蘭
    • 心臟標記測試市場—俄羅斯
  • 心臟標記測試市場 - 亞太地區
    • 亞太地區：心臟標記測試市場（按產品），2019-2032
    • 亞太地區：心臟標記測試市場（按生物標記類型），2019-2032 年
    • 亞太地區：心臟標記測試市場（按應用），2019-2032 年
    • 心臟標記測試市場 - 中國
    • 心臟標記測試市場—印度
    • 心臟標記物測試市場 - 馬來西亞
    • 心臟標記檢測市場—日本
    • 心臟標記測試市場 - 印度尼西亞
    • 心臟標記檢測市場—韓國
  • 心臟標記測試市場—中東和非洲
    • 中東和非洲：心臟標記測試市場（按產品），2019-2032
    • 中東和非洲：心臟標記測試市場（按生物標記類型），2019-2032
    • 中東和非洲：心臟標記測試市場，按應用分類，2019-2032
    • 心臟標記測試市場 - 沙烏地阿拉伯
    • 心臟標記測試市場—阿拉伯聯合大公國
    • 心臟標記測試市場—以色列
    • 心臟標記測試市場—南非
  • 心臟標記測試市場—拉丁美洲
    • 拉丁美洲：心臟標記測試市場（按產品），2019-2032 年
    • 拉丁美洲：心臟標記測試市場（按生物標記類型），2019-2032 年
    • 拉丁美洲：心臟標記測試市場，按應用劃分，2019-2032 年
    • 心臟標記測試市場—墨西哥
    • 心臟標記測試市場 - 巴西
    • 心臟標記測試市場—阿根廷

第9章 競爭格局

  • 擴張和收購分析
    • 擴張
    • 獲得
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers
  • Becton Dickson
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • LSI Medience
  • Quidel Corporation
  • Randox Laboratories
  • PerkinElmer
  • Tosoh Corporation
  • Alfa Scientific Designs
  • Response Biomedical
  • Creative Diagnostics
Product Code: PM3322

The global cardiac marker testing market size is expected to reach USD 9.73 billion by 2032, according to a new study by Polaris Market Research. The report "Cardiac Marker Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents and Kits and Instruments); By Biomarker Type; By End-User; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rapid increase in the number of cardiovascular disease patients globally in the emergency departments (EDs), the rising demand and adoption for several cardio biomarkers test like POCT, are prominent factors propelling the global market growth. Moreover, new players are continuously entering into the market with tests in order to generate maximum revenues and established players are focusing on developing and expanding their portfolio by investing in R&D activities, that are further anticipated to create growth opportunities. For instance, in January 2023, Cipla, introduced its new testing devices named 'Cippoint', a CE IVD-approved point-of-care testing device that offers testing for diabetes, infectious diseases, thyroid function, inflammation, and metabolic markers.

Moreover, the recent advances in the cardiac markers from the commercial devices to emerging technologies such as cardiac troponin and natriuretic peptides and Point-Of-Care immunoassays with improved specificity and reliability by enabling the multiplexing through the numerous molecular targets in single assays. The rising consumption of several types of unhealthy food products among millennials resulting in high number of angina pectoris cases, thus to cater the surging demand from these patient pool, adoption of cardiac biomarkers will increase rapidly.

With the drastic increase in the prevalence for cancer diseases and various other disorders and governments are heavily investing their time and money towards the development of their healthcare systems and access to advanced cardiac markers testing devices. For instance, according to a new study done by American College of Cardiology, researchers found that ApoB testing might help in the identification of patients who may still be at the high risk of cardiovascular without having normal LDL cholesterol levels.

Cardiac Marker Testing Market Report Highlights

Reagents and kits segment accounted for major global market share in 2022, on account on increasing adoption of the cardiac biomarker tests

Troponin I and T segment held the significant market revenue share in 2022, mainly due increasing demand for these devices to diagnose acute myocardial infraction

Point-of-care facilities segment is projected to grow at a highest CAGR over the study period, that is highly attributable to its growing utilization among major healthcare service providers

North America region dominated the global market in 2022, owing to high spending on healthcare infrastructure and quick adoption of advanced cardiac biomarkers in countries like US and Canada

The global key market players include: Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Medtronic PLC; Stryker Corporation; Zimmer-Biomet Holdings, Inc.; DePuy Synthes; Smith and Nephew PLC; Aesculap Implant Systems, LLC; Conmed Corporation; Donjoy, Inc.; NuVasive, Inc. and Roche

Polaris Market Research has segmented the cardiac marker testing market report based on product, biomarker type, end-user, and region:

Cardiac Marker Testing, Product Outlook (Revenue - USD Billion, 2018 - 2030)

  • Reagents and Kits
  • Instruments

Cardiac Marker Testing, Biomarker Type Outlook (Revenue - USD Billion, 2018 - 2030)

  • Troponin I and T
  • Creatine Kinase-MB (CK-MB)
  • Natriuretic Peptide
  • Myoglobin
  • High Sensitivity C-Reactive Protein
  • Other Cardiac Biomarkers

Cardiac Marker Testing, End-User Outlook (Revenue - USD Billion, 2018 - 2030)

  • Laboratory Testing Facilities
  • Point-Of-Care Testing Facilities
  • Academic Institutions

Cardiac Marker Testing, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cardiac Marker Testing Market Insights

  • 4.1. Cardiac Marker Testing Market - Biomarker Type Snapshot
  • 4.2. Cardiac Marker Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of cardiovascular diseases
      • 4.2.1.2. High technological advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Technical issues related to sample collection and storage
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cardiac Marker Testing Market Biomarker Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cardiac Marker Testing Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Reagents and Kits
    • 5.3.1. Global Cardiac Marker Testing Market, by Reagents and Kits, by Region, 2019-2032 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Cardiac Marker Testing Market, by Instruments, by Region, 2019-2032 (USD Billion)

6. Global Cardiac Marker Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Laboratory Testing Facilities
    • 6.3.1. Global Cardiac Marker Testing Market, by Laboratory Testing Facilities, by Region, 2019-2032 (USD Billion)
  • 6.4. Point-Of-Care Testing Facilities
    • 6.4.1. Global Cardiac Marker Testing Market, by Point-Of-Care Testing Facilities, by Region, 2019-2032 (USD Billion)
  • 6.5. Academic Institutions
    • 6.5.1. Global Cardiac Marker Testing Market, by Academic Institutions, by Region, 2019-2032 (USD Billion)

7. Global Cardiac Marker Testing Market, by Biomarker Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • 7.3. Troponin I and T
    • 7.3.1. Global Cardiac Marker Testing Market, by Troponin I and T, By Region, 2019-2032 (USD Billion)
  • 7.4. Creatine Kinase-MB (CK-MB)
    • 7.4.1. Global Cardiac Marker Testing Market, by Creatine Kinase-MB (CK-MB), By Region, 2019-2032 (USD Billion)
  • 7.5. Natriuretic Peptide
    • 7.5.1. Global Cardiac Marker Testing Market, by Natriuretic Peptide, By Region, 2019-2032 (USD Billion)
  • 7.6. Myoglobin
    • 7.6.1. Global Cardiac Marker Testing Market, by Myoglobin, By Region, 2019-2032 (USD Billion)
  • 7.7. High-Sensitivity C-Reactive Protein
    • 7.7.1. Global Cardiac Marker Testing Market, by High-Sensitivity C-Reactive Protein, By Region, 2019-2032 (USD Billion)
  • 7.8. Other Cardiac Biomarkers
    • 7.8.1. Global Cardiac Marker Testing Market, by Other Cardiac Biomarkers, By Region, 2019-2032 (USD Billion)

8. Global Cardiac Marker Testing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cardiac Marker Testing Market - North America
    • 8.3.1. North America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Cardiac Marker Testing Market - U.S.
      • 8.3.4.1. U.S.: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Cardiac Marker Testing Market - Canada
      • 8.3.5.1. Canada: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Cardiac Marker Testing Market - Europe
    • 8.4.1. Europe: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Cardiac Marker Testing Market - UK
      • 8.4.4.1. UK: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Cardiac Marker Testing Market - France
      • 8.4.5.1. France: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Cardiac Marker Testing Market - Germany
      • 8.4.6.1. Germany: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Cardiac Marker Testing Market - Italy
      • 8.4.7.1. Italy: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Cardiac Marker Testing Market - Spain
      • 8.4.8.1. Spain: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Cardiac Marker Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Cardiac Marker Testing Market - Russia
      • 8.4.10.1. Russia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Cardiac Marker Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Cardiac Marker Testing Market - China
      • 8.5.4.1. China: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Cardiac Marker Testing Market - India
      • 8.5.5.1. India: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Cardiac Marker Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Cardiac Marker Testing Market - Japan
      • 8.5.7.1. Japan: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Cardiac Marker Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Cardiac Marker Testing Market - South Korea
      • 8.5.9.1. South Korea: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Cardiac Marker Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Cardiac Marker Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Cardiac Marker Testing Market - UAE
      • 8.6.5.1. UAE: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Cardiac Marker Testing Market - Israel
      • 8.6.6.1. Israel: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Cardiac Marker Testing Market - South Africa
      • 8.6.7.1. South Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Cardiac Marker Testing Market - Latin America
    • 8.7.1. Latin America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Cardiac Marker Testing Market - Mexico
      • 8.7.4.1. Mexico: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Cardiac Marker Testing Market - Brazil
      • 8.7.5.1. Brazil: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Cardiac Marker Testing Market - Argentina
      • 8.7.6.1. Argentina: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. F. Hoffmann-La Roche AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Abbott Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Danaher Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Siemens Healthineers
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Becton Dickson
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Bio-Rad Laboratories
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Thermo Fisher Scientific
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. LSI Medience
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Quidel Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Randox Laboratories
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. PerkinElmer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Tosoh Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Alfa Scientific Designs
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Response Biomedical
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Creative Diagnostics
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 4 Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 11 Canada: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 14 Europe: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 17 UK: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 20 France: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 26 Italy: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 29 Spain: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 35 Russia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 41 China: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 44 India: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 50 Japan: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 65 UAE: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 68 Israel: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cardiac Marker Testing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Cardiac Marker Testing Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Cardiac Marker Testing Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Biomarker Type
  • Figure 11. Global Cardiac Marker Testing Market, by Biomarker Type, 2022 & 2032 (USD Billion)
  • Figure 12. Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cardiac Marker Testing Market